Efficacy of Immunotherapy in Patients with Metastatic Mucosal or Uveal Melanoma

BACKGROUND: The objective was to assess the response rate and survival of patients with metastatic mucosal melanoma (MM) and uveal melanoma (UM) treated with anti-CTLA-4 or anti-PD-1 monoclonal antibodies (mAbs). METHODS: A multicenter retrospective study was performed in 25 dermatology departments...

Descripción completa

Detalles Bibliográficos
Autores principales: Mignard, Claire, Deschamps Huvier, Aurélie, Gillibert, André, Duval Modeste, Anne Bénédicte, Dutriaux, Caroline, Khammari, Amir, Avril, Marie-Françoise, Kramkimel, Nora, Mortier, Laurent, Marcant, Pierre, Lesimple, Thierry, Gaudy-Marqueste, Caroline, Lesage, Candice, Machet, Laurent, Aubin, François, Meyer, Nicolas, Beneton, Nathalie, Jeudy, Géraldine, Montaudié, Henri, Arnault, Jean-Philippe, Visseaux, Laetitia, Trabelsi, Sabiha, Amini-Adle, Mona, Maubec, Eve, Le Corre, Yannick, Lipsker, Dan, Wierzbicka-Hainaut, Ewa, Litrowski, Noémie, Stefan, Andreea, Brunet-Possenti, Florence, Leccia, Marie-Thérèse, Joly, Pascal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6304636/
https://www.ncbi.nlm.nih.gov/pubmed/30631354
http://dx.doi.org/10.1155/2018/1908065

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6304636/
https://www.ncbi.nlm.nih.gov/pubmed/30631354
http://dx.doi.org/10.1155/2018/1908065

Ejemplares similares